{"hands_on_practices": [{"introduction": "The first step in assigning a Gleason grade is the accurate quantification of architectural patterns observed under the microscope. This exercise simulates the morphometric analysis of a prostate biopsy, challenging you to apply the crucial principle of pooling quantitative data across multiple fields to determine the true proportion of each pattern. Mastering this foundational skill [@problem_id:4441350] is essential for avoiding common errors, such as incorrectly averaging percentages, and for correctly identifying the primary and secondary patterns that form the basis of the Gleason score.", "problem": "A prostate needle biopsy is assessed across ten non-overlapping high-power fields using a morphometric point grid that yields area estimates (in $\\mathrm{mm}^{2}$) for invasive carcinoma subpatterns and intraductal carcinoma. Use the following foundational principles and definitions from the International Society of Urological Pathology (ISUP): (i) Gleason pattern $3$ and Gleason pattern $4$ are architectural patterns of invasive prostate adenocarcinoma; (ii) intraductal carcinoma of the prostate (IDC-P) is excluded from Gleason grading and therefore must be excluded from any computation of proportions of invasive patterns; (iii) the percent pattern $4$ for a specimen is defined as the fraction of all invasive carcinoma that is pattern $4$ pooled across the entire specimen (not the average of per-field fractions); (iv) the predominant pattern is the pattern with the greater pooled proportion among the invasive carcinoma.\n\nFor each field $i \\in \\{1,\\dots,10\\}$, you are given the measured areas of invasive Gleason pattern $3$ ($A_{3,i}$), invasive Gleason pattern $4$ ($A_{4,i}$), and intraductal carcinoma ($A_{\\mathrm{IDC},i}$). Benign tissue is not listed and is irrelevant to the computation aside from the fact that it is not included in the invasive carcinoma totals. The data are:\n- Field $1$: $A_{3,1}=0.72$, $A_{4,1}=0.18$, $A_{\\mathrm{IDC},1}=0.00$.\n- Field $2$: $A_{3,2}=0.50$, $A_{4,2}=0.35$, $A_{\\mathrm{IDC},2}=0.05$.\n- Field $3$: $A_{3,3}=0.40$, $A_{4,3}=0.10$, $A_{\\mathrm{IDC},3}=0.00$.\n- Field $4$: $A_{3,4}=0.00$, $A_{4,4}=0.30$, $A_{\\mathrm{IDC},4}=0.00$.\n- Field $5$: $A_{3,5}=0.60$, $A_{4,5}=0.20$, $A_{\\mathrm{IDC},5}=0.00$.\n- Field $6$: $A_{3,6}=0.25$, $A_{4,6}=0.15$, $A_{\\mathrm{IDC},6}=0.05$.\n- Field $7$: $A_{3,7}=0.10$, $A_{4,7}=0.00$, $A_{\\mathrm{IDC},7}=0.00$.\n- Field $8$: $A_{3,8}=0.35$, $A_{4,8}=0.40$, $A_{\\mathrm{IDC},8}=0.00$.\n- Field $9$: $A_{3,9}=0.00$, $A_{4,9}=0.00$, $A_{\\mathrm{IDC},9}=0.00$.\n- Field $10$: $A_{3,10}=0.05$, $A_{4,10}=0.05$, $A_{\\mathrm{IDC},10}=0.02$.\n\nUsing only invasive carcinoma areas, compute the pooled fraction of pattern $4$, defined as\n$$\np=\\frac{\\sum_{i=1}^{10} A_{4,i}}{\\sum_{i=1}^{10} \\left(A_{3,i}+A_{4,i}\\right)}.\n$$\nThen determine the predominant pattern under the standardized rule that the predominant pattern is the one with the larger pooled invasive area. Report:\n- The fraction $p$ as a decimal (not a percentage), rounded to three significant figures.\n- The predominant pattern as an integer code, where $3$ denotes Gleason pattern $3$ and $4$ denotes Gleason pattern $4$.\n\nExpress your final answer as a two-entry row matrix $\\left(p \\;\\; d\\right)$, where $d$ is the predominant pattern code. Do not include any units or symbols other than numbers in the matrix.", "solution": "The problem is evaluated as valid. It is scientifically grounded in the principles of prostate cancer pathology as defined by the International Society of Urological Pathology (ISUP), is well-posed with sufficient and consistent data, and is expressed in objective, formal language. The solution can therefore proceed.\n\nThe objective is to compute two quantities based on the provided area measurements of prostate carcinoma from ten high-power fields: the pooled fraction of Gleason pattern $4$ invasive carcinoma, denoted by $p$, and the predominant invasive pattern, denoted by an integer code $d$.\n\nThe problem provides the measured areas for invasive Gleason pattern $3$ ($A_{3,i}$), invasive Gleason pattern $4$ ($A_{4,i}$), and intraductal carcinoma ($A_{\\mathrm{IDC},i}$) for each field $i \\in \\{1,\\dots,10\\}$.\n\nAccording to foundational principle (ii), intraductal carcinoma of the prostate (IDC-P) is excluded from Gleason grading and computations of proportions of invasive patterns. Therefore, the values of $A_{\\mathrm{IDC},i}$ are disregarded for all calculations.\n\nThe pooled fraction of pattern $4$, $p$, is defined as the ratio of the total area of pattern $4$ to the total area of all invasive carcinoma (pattern $3$ and pattern $4$). The formula is given as:\n$$\np = \\frac{\\sum_{i=1}^{10} A_{4,i}}{\\sum_{i=1}^{10} \\left(A_{3,i}+A_{4,i}\\right)}\n$$\nFirst, we calculate the total area of invasive Gleason pattern $4$ by summing the respective areas across all $10$ fields. Let this be $A_{4,\\text{total}}$.\n$$\nA_{4,\\text{total}} = \\sum_{i=1}^{10} A_{4,i} = A_{4,1} + A_{4,2} + A_{4,3} + A_{4,4} + A_{4,5} + A_{4,6} + A_{4,7} + A_{4,8} + A_{4,9} + A_{4,10}\n$$\nSubstituting the given values (in $\\mathrm{mm}^{2}$):\n$$\nA_{4,\\text{total}} = 0.18 + 0.35 + 0.10 + 0.30 + 0.20 + 0.15 + 0.00 + 0.40 + 0.00 + 0.05 = 1.73\n$$\n\nNext, we calculate the total area of invasive Gleason pattern $3$ by summing the respective areas across all $10$ fields. Let this be $A_{3,\\text{total}}$.\n$$\nA_{3,\\text{total}} = \\sum_{i=1}^{10} A_{3,i} = A_{3,1} + A_{3,2} + A_{3,3} + A_{3,4} + A_{3,5} + A_{3,6} + A_{3,7} + A_{3,8} + A_{3,9} + A_{3,10}\n$$\nSubstituting the given values (in $\\mathrm{mm}^{2}$):\n$$\nA_{3,\\text{total}} = 0.72 + 0.50 + 0.40 + 0.00 + 0.60 + 0.25 + 0.10 + 0.35 + 0.00 + 0.05 = 2.97\n$$\n\nThe denominator of the fraction $p$ is the total area of all invasive carcinoma, which is the sum of the total areas of pattern $3$ and pattern $4$. Let this be $A_{\\text{invasive,total}}$.\n$$\nA_{\\text{invasive,total}} = A_{3,\\text{total}} + A_{4,\\text{total}} = 2.97 + 1.73 = 4.70\n$$\n\nNow, we can compute the fraction $p$:\n$$\np = \\frac{A_{4,\\text{total}}}{A_{\\text{invasive,total}}} = \\frac{1.73}{4.70} \\approx 0.3680851...\n$$\nThe problem requires this value to be rounded to three significant figures. The first three significant figures are $3$, $6$, and $8$. The fourth digit is $0$, so we round down.\n$$\np \\approx 0.368\n$$\n\nTo determine the predominant pattern, we use principle (iv), which states that the predominant pattern is the one with the greater pooled proportion, or equivalently, the greater pooled area among the invasive carcinoma. We compare the total areas $A_{3,\\text{total}}$ and $A_{4,\\text{total}}$.\n$$\nA_{3,\\text{total}} = 2.97\n$$\n$$\nA_{4,\\text{total}} = 1.73\n$$\nSince $A_{3,\\text{total}} > A_{4,\\text{total}}$ ($2.97 > 1.73$), Gleason pattern $3$ is the predominant pattern. The problem specifies an integer code of $3$ for pattern $3$ and $4$ for pattern $4$. Therefore, the predominant pattern code is $d=3$.\n\nThe final answer is to be expressed as a two-entry row matrix $(p \\;\\; d)$.\nThe computed values are $p=0.368$ and $d=3$.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.368 & 3\n\\end{pmatrix}\n}\n$$", "id": "4441350"}, {"introduction": "Beyond identifying the primary and secondary patterns, a pathologist must correctly handle the presence of minor, higher-grade components, which can disproportionately affect prognosis. This practice focuses on the specific rules for 'tertiary patterns' in radical prostatectomy specimens, particularly the critical 5% threshold for Gleason pattern 5. By working through this scenario [@problem_id:4441336], you will learn how even a small, but significant, amount of a high-grade pattern can elevate the final Gleason score and ISUP Grade Group, directly impacting patient risk stratification and management.", "problem": "A radical prostatectomy specimen of prostate adenocarcinoma is reviewed. Histologic quantification of architectural patterns shows that pattern $4$ comprises $55\\%$ of the tumor, pattern $5$ comprises $5\\%$, and the remainder is pattern $3$. The case was initially signed out as Gleason score $7$ written as $\\left(3+4\\right)$, but the laboratory requires verification of the final reportable combined Gleason score and International Society of Urological Pathology (ISUP) Grade Group after applying standard tertiary pattern handling rules. For radical prostatectomy, the primary pattern is defined as the most prevalent pattern, the secondary pattern is the second most prevalent, and a minor higher-grade pattern constituting less than $5\\%$ of the tumor is recorded as a tertiary pattern and is not incorporated into the two-pattern combined Gleason score; if the higher-grade component is at least $5\\%$, it must be incorporated into the combined score. The ISUP Grade Group mapping is based on the combined Gleason score as follows: combined score $6$ corresponds to ISUP Grade Group $1$, combined score $7$ written as $\\left(3+4\\right)$ corresponds to ISUP Grade Group $2$, combined score $7$ written as $\\left(4+3\\right)$ corresponds to ISUP Grade Group $3$, combined score $8$ corresponds to ISUP Grade Group $4$, and combined scores $9$ or $10$ correspond to ISUP Grade Group $5$.\n\nUsing these foundational rules, determine the final reportable combined Gleason score as a single integer and the ISUP Grade Group number. Express your final answer as a two-entry row matrix in the order $\\left[\\text{ISUP Grade Group}, \\text{Gleason score}\\right]$. No rounding is required.", "solution": "The problem is to determine the correct combined Gleason score and ISUP Grade Group for a radical prostatectomy specimen by applying standard tertiary pattern grading rules.\n\n1.  **Determine the percentage of each Gleason pattern:**\n    The problem states that pattern $4$ is $55\\%$ and pattern $5$ is $5\\%$. The remainder is pattern $3$.\n    Percentage of Pattern $3 = 100\\% - (55\\% + 5\\%) = 100\\% - 60\\% = 40\\%$.\n    The full distribution of patterns is:\n    *   Pattern $4$: $55\\%$\n    *   Pattern $3$: $40\\%$\n    *   Pattern $5$: $5\\%$\n\n2.  **Identify the primary, secondary, and tertiary patterns:**\n    Based on prevalence, the patterns are ranked as follows:\n    *   **Primary pattern** (most prevalent): Pattern $4$\n    *   **Secondary pattern** (second most prevalent): Pattern $3$\n    *   **Tertiary pattern**: Pattern $5$\n\n3.  **Apply the tertiary pattern grading rule:**\n    The rule for radical prostatectomy specimens states that if a higher-grade pattern (in this case, pattern $5$) constitutes **at least $5\\%$** of the tumor, it must be incorporated into the final score. Since pattern $5$ is present at exactly $5\\%$, this rule applies.\n    When this rule is invoked, the combined Gleason score is calculated as the sum of the primary pattern and the highest-grade pattern present.\n    *   Primary Pattern: $4$\n    *   Highest-Grade Pattern: $5$\n    Therefore, the correct combined Gleason Score = $4 + 5 = 9$.\n\n4.  **Determine the ISUP Grade Group:**\n    The ISUP Grade Group is determined from the final combined Gleason score. According to the provided mapping, a Gleason score of $9$ corresponds to **ISUP Grade Group 5**.\n\n5.  **Format the final answer:**\n    The required format is a two-entry row matrix $[\\text{ISUP Grade Group}, \\text{Gleason score}]$.\n    The values are $5$ and $9$.", "answer": "$$\\boxed{\\begin{pmatrix} 5 & 9 \\end{pmatrix}}$$", "id": "4441336"}, {"introduction": "A pathologist's diagnosis is a critical piece of a larger clinical puzzle used to predict patient outcomes and guide therapy. This final exercise bridges the gap between pathology and clinical practice by integrating the ISUP Grade Group with other key prognostic markers like Prostate-Specific Antigen (PSA) and tumor stage. Although the provided nomogram is a simplified model for pedagogical purposes, it illustrates the powerful principle of how quantitative tools use pathologic data to forecast clinical outcomes. By calculating a patient's risk category and estimating the probability of biochemical progression [@problem_id:4441279], you will see how these inputs are synthesized into a meaningful prognostic estimate.", "problem": "A patient is diagnosed with prostate adenocarcinoma. The following clinicopathologic features are observed at diagnosis: Prostate-Specific Antigen (PSA) is $14.0$ $\\mathrm{ng/mL}$, biopsy Grade Group is $3$, and clinical Tumor stage is $\\mathrm{cT2b}$. Use the following foundational definitions and a calibrated nomogram to determine a risk category and estimate the probability of biochemical progression within $5$ years after definitive therapy.\n\nFoundational base:\n1. D’Amico risk classification is defined by three independent criteria: PSA, Gleason grading (expressed here as Grade Group, where Grade Group $1$ corresponds to Gleason score $3+3$, Grade Group $2$ to Gleason score $3+4$, Grade Group $3$ to Gleason score $4+3$, Grade Group $4$ to Gleason score $8$, and Grade Group $5$ to Gleason score $9$–$10$), and clinical T-stage. A Low-risk designation requires all of the following: PSA $\\leq 10$, Grade Group $1$, and $\\mathrm{T1}$–$\\mathrm{T2a}$. An Intermediate-risk designation applies if at least one intermediate-risk feature is present and no high-risk features are present; intermediate-risk features include PSA $>10$ and $\\leq 20$, Grade Group $2$–$3$, or $\\mathrm{T2b}$. A High-risk designation applies if any high-risk feature is present; high-risk features include PSA $>20$, Grade Group $4$–$5$, or $\\mathrm{T2c}$–$\\mathrm{T3a}$.\n\n2. The nomogram encodes the combined effect of PSA, Grade Group, and T-stage on the $5$-year probability of biochemical progression using a points system mapped to a logistic function of the total points. Points are assigned as follows:\n   - PSA points: $P_{\\mathrm{PSA}} = 12 \\times \\ln(\\mathrm{PSA})$, where $\\ln$ denotes the natural logarithm and PSA is in $\\mathrm{ng/mL}$.\n   - Grade Group points: $P_{\\mathrm{GG}} = 0$ for Grade Group $1$, $15$ for Grade Group $2$, $28$ for Grade Group $3$, $40$ for Grade Group $4$, and $55$ for Grade Group $5$.\n   - T-stage points: $P_{\\mathrm{T}} = 0$ for $\\mathrm{T1c}$–$\\mathrm{T2a}$, $20$ for $\\mathrm{T2b}$, and $35$ for $\\mathrm{T2c}$–$\\mathrm{T3a}$.\n\n   The total points are $S = P_{\\mathrm{PSA}} + P_{\\mathrm{GG}} + P_{\\mathrm{T}}$. The $5$-year progression probability is then estimated by the logistic mapping\n   $$p = \\frac{1}{1 + \\exp\\!\\big(-(\\alpha + \\gamma S)\\big)},$$\n   with calibration constants $\\alpha = -3.2$ and $\\gamma = 0.02$.\n\nTasks:\n- Using the definitions in item $1$, determine the D’Amico risk category from the given PSA, Grade Group, and T-stage.\n- Using the nomogram in item $2$, compute the $5$-year biochemical progression probability, $p$.\n\nExpress the final probability as a decimal fraction. Round your final answer to four significant figures. Do not include a percent sign in your answer.", "solution": "The problem requires two steps: classification using the D’Amico criteria and quantitative estimation using the nomogram’s logistic mapping.\n\nStep $1$: D’Amico risk classification from definitions.\n\nBy definition, Intermediate-risk features include PSA $>10$ and $\\leq 20$, Grade Group $2$–$3$, and $\\mathrm{T2b}$; High-risk features include PSA $>20$, Grade Group $4$–$5$, and $\\mathrm{T2c}$–$\\mathrm{T3a}$. Low-risk requires simultaneously PSA $\\leq 10$, Grade Group $1$, and $\\mathrm{T1}$–$\\mathrm{T2a}$.\n\nGiven data:\n- PSA is $14.0$, which satisfies PSA $>10$ and $\\leq 20$ and is therefore an intermediate-risk feature.\n- Grade Group is $3$, which is an intermediate-risk feature (corresponding to Gleason score $4+3$).\n- T-stage is $\\mathrm{cT2b}$, which is an intermediate-risk feature.\n\nNo high-risk features are present because PSA is not $>20$, Grade Group is not $4$–$5$, and T-stage is not $\\mathrm{T2c}$–$\\mathrm{T3a}$. Therefore, by the D’Amico rules, the overall risk category is Intermediate-risk.\n\nStep $2$: Quantitative estimation using the nomogram.\n\nCompute the points for each component using the provided formulas.\n\n- PSA points:\n  $$P_{\\mathrm{PSA}} = 12 \\times \\ln(\\mathrm{PSA}) = 12 \\times \\ln(14.0).$$\n  Evaluate $\\ln(14.0)$:\n  $$\\ln(14.0) \\approx 2.6390573296.$$\n  Thus,\n  $$P_{\\mathrm{PSA}} \\approx 12 \\times 2.6390573296 \\approx 31.6686879552.$$\n\n- Grade Group points for Grade Group $3$:\n  $$P_{\\mathrm{GG}} = 28.$$\n\n- T-stage points for $\\mathrm{T2b}$:\n  $$P_{\\mathrm{T}} = 20.$$\n\nSum the points to obtain the total:\n$$S = P_{\\mathrm{PSA}} + P_{\\mathrm{GG}} + P_{\\mathrm{T}} \\approx 31.6686879552 + 28 + 20 \\approx 79.6686879552.$$\n\nMap total points $S$ to the $5$-year progression probability via the logistic function:\n$$\\eta = \\alpha + \\gamma S = -3.2 + 0.02 \\times 79.6686879552 \\approx -3.2 + 1.5933737591 \\approx -1.6066262409.$$\nThen\n$$p = \\frac{1}{1 + \\exp\\!\\big(-\\eta\\big)} = \\frac{1}{1 + \\exp\\!\\big(1.6066262409\\big)}.$$\n\nCompute $\\exp\\!\\big(1.6066262409\\big)$:\n$$\\exp\\!\\big(1.6066262409\\big) \\approx 4.9860319491.$$\n\nTherefore,\n$$p \\approx \\frac{1}{1 + 4.9860319491} \\approx \\frac{1}{5.9860319491} \\approx 0.1670598772.$$\n\nRound the final decimal fraction to four significant figures:\n$$p \\approx 0.1671.$$\n\nThis value represents the estimated probability of biochemical progression within $5$ years for this patient profile, expressed as a decimal fraction.", "answer": "$$\\boxed{0.1671}$$", "id": "4441279"}]}